PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 70.40
+0.30 (0.43%)
At close: Dec 31, 2025
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 10.11 billion as of December 31, 2025. Its market cap has decreased by -25.58% in one year.
Market Cap
10.11B
Enterprise Value
5.53B
Revenue
2.51B
Ranking
n/a
PE Ratio
6.05
Stock Price
70.40
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 10.11B, an increase of 88.06%. That is a compound annual growth rate of 4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 250.47B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |